Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
A Past filled with Old Civilizations: The World's Most established Societies - 2Birutė Galdikas: The last of the ‘angels’ in primatology’s most extraordinary chapter
- 3Pick Your Favored kind of books
- 44 astronauts are en route home from ISS after medical issue forces early exit
- 5Exclusive new photos from 'Michael' biopic show Jaafar Jackson as King of Pop
- Abbott issues US device correction for some glucose monitors over faulty readings risk
- Investigate the Excellence of Professional flowerbeds: A Virtual Local escort
- UN warns civil liberties under threat due to war in Middle East
- A new mom skipped a routine appointment. An infected cut led to a devastating diagnosis
- Why don’t humans have hair all over their bodies? A biologist explains our lack of fur
- Well known Tea Brands for Each Tea Sweetheart
- Ancient mass grave discovered in water cistern during Tel Azekah excavations
- 4 Excellent Remote Headphones of 2024
- 10 Demonstrated Tips to Dominate Video Altering on Your Cell phone in 2023
